Advertisement

Topics

Five Prime Enters Transition Phase; Multiple Trials Planned In Next 12 Months

12:43 EDT 4 Jul 2017 | SCRIP

Five Prime, in partnership with immunotherapy giant Bristol-Myers Squibb, will launch several pivotal trials in the next 12 months for...

      

Related Stories

 

Original Article: Five Prime Enters Transition Phase; Multiple Trials Planned In Next 12 Months

NEXT ARTICLE

More From BioPortfolio on "Five Prime Enters Transition Phase; Multiple Trials Planned In Next 12 Months"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...